ClusterOS Diagnostic Profile
Cambridgeshire Peterborough Life Sciences
Cambridgeshire Peterborough Life Sciences draws £2.21bn of UKRI lead-led funding across 6,935 grants, anchored by Cambridge (24%), Babraham Institute (13%), with Glaxosmithkline (Gsk) on the industrial side. 45 Companies House-traced spin-outs translate to £49m UKRI per spin-out.
The cluster shows medium-confidence "Re-proving instead of narrowing" and "Coordinating instead of deciding" behaviour — multi-actor coordination distributes risk across institutional partners without forcing the strategic option-collapse that would convert capability into a defined pathway.
Tap diagram to enlarge
Same data examined through five diagnostic lenses — Pipeline, Leverage, Triple Helix, Throughput, Collaboration. The interactive diagnostic is currently in private preview.
Sources: UKRI Gateway to Research (grants, outcomes); OpenAlex (publications); Companies House (spin-out lifecycle); DSIT (cluster mapping); Public investment data. Snapshot May 2026.
Stabilisation stacks · Why single interventions fail
Intermediaries produce narrative about their facilitation role; narrative legitimises intermediary existence and funding; uncertainty about direct coupling absorbed by narrative rather than demonstration.
"If one documented case of direct coupling (e.g., a university researcher and a company collaborating directly without Cambridge Enterprise technology transfer involvement, or two companies partnering without One Nucleus or accelerator brokerage) were publicized with outcome data (patent filed, product launched, funding secured), it might shift the burden of proof by demonstrating that direct coupling can work without intermediation."
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
Structural resemblances · Clusters with similar stall configurations
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.